Cargando…
Developing a Prognostic Micro-RNA Signature for Human Cervical Carcinoma
Cervical cancer remains the third most frequently diagnosed and fourth leading cause of cancer death in women worldwide. We sought to develop a micro-RNA signature that was prognostic for disease-free survival, which could potentially allow tailoring of treatment for cervical cancer patients. A cand...
Autores principales: | How, Christine, Pintilie, Melania, Bruce, Jeff P., Hui, Angela B. Y., Clarke, Blaise A., Wong, Philip, Yin, Shaoming, Yan, Rui, Waggott, Daryl, Boutros, Paul C., Fyles, Anthony, Hedley, David W., Hill, Richard P., Milosevic, Michael, Liu, Fei-Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4399941/ https://www.ncbi.nlm.nih.gov/pubmed/25880806 http://dx.doi.org/10.1371/journal.pone.0123946 |
Ejemplares similares
-
Chromosomal instability as a prognostic marker in cervical cancer
por: How, Christine, et al.
Publicado: (2015) -
MicroRNA-196b Regulates the Homeobox B7-Vascular Endothelial Growth Factor Axis in Cervical Cancer
por: How, Christine, et al.
Publicado: (2013) -
The predictive value of nadir neutrophil count during treatment of cervical cancer: Interactions with tumor hypoxia and interstitial fluid pressure (IFP)
por: Glicksman, Rachel, et al.
Publicado: (2017) -
Characterization of the Tumor-Microenvironment in Patient-Derived Cervix Xenografts (OCICx)
por: Chaudary, Naz, et al.
Publicado: (2012) -
Intratumoral heterogeneity and hypoxia gene expression signatures: Is a single biopsy adequate?
por: Lukovic, Jelena, et al.
Publicado: (2019)